Dosing and Administration | ANDEXXA | For HCPs
网页ANDEXXA ® (coagulation factor Xa [recombinant], inactivated-zhzo) is a recombinant modified human factor Xa (FXa) protein indicated for patients treated with rivaroxaban or …
网页2019年6月19日 · Providers will place an order for the andexanet alfa pharmacist to dose protocol and will be required to answer the following: Drug to be reversed. Strength of last dose. Timing of last dose. Indication. Receipt of other factor product, including at an outside facility. Presence of thromboembolic event in past 2 weeks.
Anticoagulation Reversal Agent | ANDEXXA | For HCPs
网页ANDEXXA ® (coagulation factor Xa [recombinant], inactivated-zhzo) is a recombinant modified human factor Xa (FXa) protein indicated for patients treated with rivaroxaban or apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding. This indication is approved under accelerated approval based on the ...
网页ANDEXXA (coagulation factor Xa (recombinant), inactivated-zhzo) is a recombinant modifiedhuman factor Xa (FXa) protein indicatedfor patients treated with rivaroxaban or apixaban, when reversal of...
Andexanet Alfa - StatPearls - NCBI Bookshelf
网页2023年8月8日 · Andexanet alfa is a recombinant modified Factor Xa protein approved by the FDA in May 2018 to reverse apixaban and rivaroxaban in patients with life-threatening or uncontrolled bleeding. Anticoagulation reversal is often a critical need when therapy does not work as planned and bleeding ensues.
Andexxa - AstraZeneca US
网页Due to the reversible binding of ANDEXXA to the FXa inhibitor, the high sample dilution currently used in commercial clinical assays promotes dissociation of the inhibitor from ANDEXXA, resulting in detection of erroneously elevated anti-FXa activity levels, thereby causing a substantial underestimation of the reversal activity of ANDEXXA ...
Andexanet Alfa (Andexxa®) for the Reversal of Direct Oral ...
网页Andexanet alfa (Andexxa ®) for the reversal of direct oral anticoagulants. Keywords: andexanet alfas, apixaban, rivaroxaban, bleeding, reversal, antidote, Andexxa. Go to: Oral anticoagulants are the medication of choice for the prevention of stroke in atrial fibrillation (AF) and the treatment of venous thromboembolism (VTE).
Use of Andexanet Alfa for Factor Xa Inhibitor Reversal in US …
网页Major bleeding events (MBEs) are life-threatening, increasing both the morbidity and mortality for trauma patients presenting on oral anticoagulant therapy. 1 – 3 Andexanet alfa, also known as Andexxa, is a modified recombinant inactive form of human factor Xa (factor Xa decoy protein) developed for the reversal of factor Xa inhibitors that ...
Andexanet for Factor Xa Inhibitor–Associated Acute Intracerebral ...
网页2024年5月15日 · Andexanet alfa is a modified recombinant inactive form of human factor Xa, which binds and sequesters factor Xa inhibitor molecules, rapidly reducing anti–factor Xa activity and restoring...
Full Study Report of Andexanet Alfa for Bleeding Associated …
网页2019年2月7日 · The Andexanet Alfa, a Novel Antidote to the Anticoagulation Effects of Factor Xa Inhibitors (ANNEXA-4) study is a single-group cohort study designed to assess the efficacy and safety...
跳至内容